Clinical Outcomes of Double Filtration Plasmapheresis in Guillain–Barré Syndrome: A Single‐Center Retrospective Study
Therapeutic Apheresis and Dialysis · 19.08.2026
DOI: 10.1002/1744-9987.70211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 19.08.2026. Verfasst von Jingwen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
Guillain–Barré syndrome (GBS) is an acute immune‐mediated peripheral neuropathy for which therapeutic apheresis is an established treatment option. Various treatment modalities, including double filtration plasmapheresis (DFPP), are widely used in clinical practice; however, real‐world data on their clinical outcomes and adjunctive treatment strategies remain limited.
Methods
We retrospectively analyzed 43 patients with GBS treated at a single tertiary center between June 2018 and October 2024, including 36 patients who received DFPP‐containing regimens and 7 who received IVIG alone. Short‐term functional outcomes were assessed using the modified Rankin scale (mRS) and Hughes functional grading scale (HFGS) at hospital admission before treatment and after completion of inpatient treatment. Changes in immunoglobulin and complement levels were evaluated in patients receiving DFPP. Exploratory analyses compared functional score changes across different treatment regimens.
Results
At hospital discharge, mRS and HFGS scores were significantly lower than baseline in patients receiving DFPP alone, DFPP combined with intravenous methylprednisolone, or IVIG alone. No significant differences in changes in functional scores were observed between the DFPP‐alone and IVIG‐alone groups or between the DFPP‐alone and DFPP‐plus‐corticosteroid groups. DFPP significantly reduced serum immunoglobulin and complement levels; however, the percentage reductions in IgG, IgA, and IgM were not significantly correlated with short‐term changes in mRS or HFGS scores.
Conclusion
In this real‐world cohort, DFPP‐containing treatment was associated with short‐term improvement in functional scores from hospital admission to hospital discharge. No statistically significant difference in short‐term functional improvement was detected between the DFPP‐alone and DFPP‐plus‐IVMP groups. However, the small sample size, heterogeneous treatment regimens, and lack of long‐term follow‐up preclude conclusions regarding sustained or comparative efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Jingwen Li, Wenbin Wan
Zitieren
APA
Li, J., Chen, Y., Wu, J., Mei, Y., Ni, L., Qiu, H., Zhou, Y., Zhang, Y., & Wan, W. (2026). Clinical Outcomes of Double Filtration Plasmapheresis in Guillain–Barré Syndrome: A Single‐Center Retrospective Study. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70211
Vancouver
Li J, Chen Y, Wu J, Mei Y, Ni L, Qiu H, et al. Clinical Outcomes of Double Filtration Plasmapheresis in Guillain–Barré Syndrome: A Single‐Center Retrospective Study. Therapeutic Apheresis and Dialysis. 2026. doi:10.1002/1744-9987.70211
BibTeX
@article{Li2026,
author = {Li, Jingwen and Chen, Ying and Wu, Jun and Mei, Yufang and Ni, Liping and Qiu, Huiying and Zhou, Yan and Zhang, Ying and Wan, Wenbin},
title = {Clinical Outcomes of Double Filtration Plasmapheresis in Guillain–Barré Syndrome: A Single‐Center Retrospective Study},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1002/1744-9987.70211}
}
EUVIMED